Related Experiment Video
Updated: Apr 16, 2026
14:45
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
15.6K
Recent developments in clinical trial designs for HIV vaccine research
Laura Richert1, Edouard Lhomme, Catherine Fagard
1a University of Bordeaux, ISPED ; Bordeaux , France.
Human Vaccines & Immunotherapeutics
|March 10, 2015
Summary
Developing effective HIV vaccine strategies requires efficient clinical trials. This review explores recent advances in trial designs to accelerate the development of both prophylactic and therapeutic HIV vaccines.
Area of Science:
- Immunology
- Vaccinology
- Clinical Trials
Background:
- HIV vaccine development is critical for epidemic control.
- The process is lengthy and methodologically challenging due to a lack of validated correlates of protection.
- Candidate vaccines exist for both prophylactic and therapeutic uses.
Purpose of the Study:
- To review recent advances in clinical trial designs for HIV vaccine strategies.
- To enhance the efficiency of clinical development for candidate HIV vaccines.
- To address methodological challenges in HIV vaccine development.
Main Methods:
- Discussion of recent advances in clinical trial designs.
- Analysis of methodological aspects for early-stage (Phase I/II) and later-stage (Phase IIB/III) development.
- Consideration of specificities for prophylactic and therapeutic HIV vaccine development.
Main Results:
- Recent advances in clinical trial designs can increase development efficiency.
- Methodological considerations are crucial for both early and late-stage trials.
- Tailoring designs to prophylactic and therapeutic vaccines is important.
Conclusions:
- Improved clinical trial designs are essential for accelerating HIV vaccine development.
- Addressing methodological challenges, particularly correlates of protection, is key.
- Efficient development pathways are needed for both prophylactic and therapeutic HIV vaccines.
Related Concept Videos
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
398
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
398
01:20Study Designs in Epidemiology
1.6K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.6K
01:16Clinical Trials
11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.2K
01:11Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
387
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
387
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
579
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
579